Prevalence of hypermutators among clinical Acinetobacter baumannii isolates

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 3, 2016, Pages 661-665

  Komp Lindgren, Patricia ^a   Higgins, Paul G ^b   Seifert, Harald ^b   Cars, Otto ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; DOXYCYCLINE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; RIFAMPICIN; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MUTATION; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; EPSILOMETER TEST; MICROBIAL POPULATION DYNAMICS; MUTATION RATE; NONHUMAN; ACINETOBACTER INFECTION; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, BACTERIAL; MUTATION RATE; RIFAMPIN;

EID: 84960795783     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv378     Document Type: Article

References (20)

1. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21: 538-82.
2. Poirel L, Bonnin RA, Nordmann P. Genetic basis of antibiotic resistance in pathogenic Acinetobacter species. IUBMB Life 7 2011; 63: 1061-7.
3. Woodford N, Ellington MJ. The emergence of antibiotic resistance by mutation. Clin Microbiol Infect 2007; 13: 5-18.
4. Townsend JP, Nielsen KM, Fisher DS et al. Horizontal acquisition of divergent chromosomal DNA in bacteria: effects of mutator phenotypes. Genetics 2003; 164: 13-21.
5. Maisnier-Patin S, Andersson DI. Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution. Res Microbiol 2004; 155: 360-9.
6. Hall LMC, Henderson-Begg SK. Hypermutable bacteria isolated from humans-a critical analysis. Microbiology 2006; 152: 2505-14.
7. Higgins PG, Janssen K, Fresen MM et al. Molecular epidemiology of Acinetobacter baumannii bloodstream isolates obtained in the United States from 1995 to 2004 using rep-PCR and multilocus sequence typing. J Clin Microbiol 2012; 50: 3493-500.
8. Wisplinghoff H, Hippler C, Bartual SG et al. Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme. Clin Microbiol Infect 2008; 14: 708-15.
9. Orlen H, Hughes D. Weak mutators can drive the evolution of fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother 2006; 50: 3454-6.
10. EUCAST. Breakpoint Tables for Interpretation of MICs and Zone Diameters, Version 4.0. EUCAST. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/Breakpoint_table_v_4.0.pdf.
11. Baquero MR, Nilsson AI, Turrientes MC et al. Polymorphic mutation frequencies in Escherichia coli: emergence of weak mutators in clinical isolates. J Bacteriol 2004; 186: 5538-42.
12. Turrientes MC, Baquero MR, Sánchez MB et al. Polymorphic mutation frequencies of clinical and environmental Stenotrophomonas maltophilia populations. Appl Environ Microbiol 2010; 76: 1746-58.
13. Komp Lindgren P, Karlsson A, Hughes D. Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob Agents Chemother 2003; 47: 3222-32.
14. Denamur E, Tenaillon O, Deschamps C et al. Intermediate mutation frequencies favor evolution of multidrug resistance in Escherichia coli. Genetics 2005; 171: 825-7.
15. Miller K, O'Neill AJ, Chopra I. Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes. J Antimicrob Chemother 2002; 49: 925-34.
16. Feliziani S, Marvig RL, Luján AM et al. Coexistence and within-host evolution of diversified lineages of hypermutable Pseudomonas aeruginosa in long-term cystic fibrosis infections. PLoS Genet 2014; 10: e1004651.
17. Matic I, Rayssiguier C, Radman M. Interspecies gene exchange in bacteria: the role of SOS and mismatch repair systems in evolution of species. Cell 1995; 80: 507-15.
18. Denamur E, Matic I. Evolution of mutation rates in bacteria. Mol Microbiol 2006; 60: 820-7.
19. Zander E, Chmielarczyk A, Heczko P et al. Conversion of OXA-66 into OXA-82 in clinical Acinetobacter baumannii isolates and association with altered carbapenem susceptibility. J Antimicrob Chemother 2013; 68: 308-11.
20. Bertini A, Poirel L, Bernabeu S et al. Multicopy blaOXA-58 gene as a source of high-level resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother 2007; 51: 2324-8.